Registrieren

Registierung erfolgt in Kürze...
Fleebs-Logo
Details werden geladen...

Scholar Rock Says FDA Review Of Apitegromab BLA Continues; Approval Decision Expected By Sept. 30 | 08.08.26 | finanzen.ch

(RTTNews) - Scholar Rock Holding Corp. (SRRK) said Friday the U.S. Food and Drug Administration will continue reviewing the Biologics License Appl...

Videos

Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio
21 Minuten 10 Sekunden

Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio

Ähnliche Seiten

https://www.finanzen.at/nachrichten/aktien/scholar-rock-says-fda-review-of-apitegromab-bla-continues;-approval-decision-expected-by-sept-30-1036431532

Scholar Rock Says FDA Review Of Apitegromab BLA Continues; Approval Decision Expected By Sept. 30 | 08.08.26 | finanzen.at

https://www.finanzen.at/nachrichten/aktien/scholar-rock-says-fda-review-of-apitegromab-bla-continues;-approval-decision-expected-by-sept-30-1036431532